£26.0M
The life sciences software provider raised the capital from Horizons Ventures and Sofinnova Partners to fund commercial growth.
Synthace
Synthace provides a cloud platform that enables life scientists to automate experiments and share insights.
£26.0MTotal raised
Synthace operates a cloud platform that helps life sciences organisations automate biology experimentation and share insights. Seven of the top ten global pharmaceutical companies use its software.
Categories
Team
GL
Guy Levy-Yurista
CEO